Jakob Juul Rasmussen: Zero cost technology - transforming how smaller companies oversee their assets episode artwork

EPISODE · Mar 31, 2022 · 45 MIN

Jakob Juul Rasmussen: Zero cost technology - transforming how smaller companies oversee their assets

from Lab to Lives

Send us Fan MailSam and Ivanna speak to Jakob Juul Rasmussen about the stubborn prevalence of paper in clinical trials, especially in small pharmaceutical and biotech companies. Paying money up front, covering the implementation and license costs and building up internal IT functions can be prohibitive for small pharmaceutical and biotech companies. This leads many companies to outsource their entire IT landscape to CROs. As a result, control over assets becomes complicated and cumbersome, as your clinical data risks being stored in different applications with multiple data models applied.  Standard configuration is helping bridge the gap, but compliance requirements from authorities for both internal and CRO-maintained software are unchanged. Jakob suggests a radical third way of getting the set of applications needed to run the business of any biotech or pharmaceutical company, without resorting to paper or complete outsourcing, transforming both how technology companies deliver IT solutions and how IT is anchored with the sponsor companies. “Small companies really want to focus on science and just have the necessary tools to provide the best science”Jakob Juul RasmussenNotesGuest Jakob Juul Rasmussen : https://www.linkedin.com/in/jakobjuulrasmussen/ PharmaIT: https://pharmait.dk/ ISPE GAMP 5 https://ispe.org/publications/guidance-documents/gamp-5 ALCOA ++ https://www.gmp-compliance.org/gmp-news/alcoa-what-does-it-mean Pharmacovigilance Signal Detection: https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management EMA Notice to Sponsors on Validation and Qualification of Computerized Systems used for Clinical Trials: ​​https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/notice-sponsors-validation-qualification-computerised-systems-used-clinical-trials_en.pdfhttps://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/notice-sponsors-validation-qualification-computerised-systems-used-clinical-trials_en.pdf DIA Reference models: https://www.diaglobal.org/en/resources/tools-and-downloads Technology mentionedQuality Management System (QMS)Electronic Trial Master File (eTMF)Electronic Case Report Form (eCRF)Regulatory Information Management System (RIMS)BoxDropboxSharePointTeamsWord Electronic Signature Functions mentionedCROs  ITAbbreviations & DefinitionseCRF: Electronic Case Report FormeTMF: Electronic Trial Master FileEDC: Electronic Data CaptureFDA: Food and Drug Administration QMS: Quality Management SystemRIMS: Regulatory Information Management System Visit Labtolives.com Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn pageVisit www.labtolives.com HostsAlexander Booth aka the MedTech GuyDimitri Borisevich aka the start-up GuyIvanna Rosendal aka the R&D pharma Gal

Episode metadata supplied by the publisher feed · Published Mar 31, 2022

Embed this episode

Send us Fan Mail Sam and Ivanna speak to Jakob Juul Rasmussen about the stubborn prevalence of paper in clinical trials, especially in small pharmaceutical and biotech companies. Paying money up front, covering the implementation and license costs and building up internal IT functions can be prohibitive for small pharmaceutical and biotech companies. This leads many companies to outsource their entire IT landscape to CROs. As a result, control over assets becomes complicated and cumbersome, a...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Jakob Juul Rasmussen: Zero cost technology - transforming how smaller companies oversee their assets

0:00 45:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lab to Lives?

This episode is 45 minutes long.

When was this Lab to Lives episode published?

This episode was published on March 31, 2022.

Can I download this Lab to Lives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!